Will Life on Mars Require a Genetic Rewrite?
By Scott Solomon,
The MIT Press Reader
| 02. 12. 2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp autumn morning. “Just so I can get there faster. Not because I’m late for a meeting, just because it’s taking too long to walk…I’m the only one I know who runs to work to get there faster."
Mason is a professor of physiology and biophysics at Weill Cornell Medicine. At least that’s his official title. He seems to be working on a hundred different projects all at once, ranging from tracking changes in the virus that causes COVID-19 to helping corals adapt to climate change.
The previous day, I had visited his research group on the Upper East Side. The Mason Lab occupied four separate laboratories across three buildings and was still growing. Although they were pursuing a wide range of projects, a major focus of their work was on how the human genome and microbiome are affected by spaceflight...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...